Note: This website was automatically translated, so some terms or nuances may not be completely accurate.
Ms. Tsuruno conducts a public lecture on "L-92 lactic acid bacteria" ahead of flu season.
On December 17, Calpis held a PR event for its proprietary strain "L-92 lactic acid bacteria" at Bellesalle Roppongi in Minato Ward, Tokyo. Research by the Calpis Fermentation Research Institute revealed through human trials that consuming L-92 lactic acid bacteria increases the concentration of "IgA antibodies" in saliva. The company presented these findings at the Japanese Society for Food Immunology conference in October. IgA antibodies are secreted from the mucous membranes of the nose and mouth into saliva and nasal mucus, where they have been confirmed to block the entry of influenza viruses.
The event featured popular TV personality Tsuru Takeshi, known as an "Ikumen" (hands-on dad) raising children, as the instructor. He conducted a public lecture on the lactic acid bacteria for general "Ikumen" attendees.
A video shown at the beginning humorously depicted Tsuru being asked to become an "L-92 Lactobacillus" master. This involved a four-week study of lactobacillus and a challenge to see if consuming it would increase his IgA antibody concentration.
Following six student dads, Tsuru and Sae Yanagihara from the research institute took the stage as class advisors. Tsuru began by urging dads to recognize that "managing family health is now dad's domain." She then revealed that lactic acid bacteria, known for their intestinal regulation effects, have also been confirmed to inhibit influenza virus infection, stating, "'Protecting the family and working energetically' is the motto for dads and lactic acid bacteria." Using the phrase "Catch the virus to protect your family," she gently explained how taking L-92 lactic acid bacteria increases IgA antibodies, enabling the body to envelop and expel bacteria and viruses.
Finally, when Tsuruno-san shouted, "Protect your family with L-92 lactic acid bacteria!", everyone responded with "Virus catch!", and the lesson ended in a warm and friendly atmosphere.
It was announced that after four weeks of consuming L-92 lactic acid bacteria, Tsuruno's IgA antibody concentration in saliva increased to 137 (with pre-study levels set at 100), reaffirming the efficacy of L-92 lactic acid bacteria. Tsuruno expressed delight, saying it gave her a sense of security, like wearing an "internal mask." Yanagihara-san praised Tsuruno-san's knowledge of L-92 lactic acid bacteria as "master-level," recognizing her study achievements, and presented her with a Master Certification from the research institute. Tsuruno-san concluded, "As we approach the peak of influenza season, I want to continue taking L-92 lactic acid bacteria to protect my own and my family's health."
Calpis Related Site: http://www.calpis.co.jp/l92_challenge/?cid=adw1512_L92
Was this article helpful?
Share this article
